Trusted by Students Everywhere
Why Choose Us?
0% AI Guarantee
Human-written only.
24/7 Support
Anytime, anywhere.
Plagiarism Free
100% Original.
Expert Tutors
Masters & PhDs.
100% Confidential
Your privacy matters.
On-Time Delivery
Never miss a deadline.
AstraZeneca is developing a vaccine to combat COVID19
AstraZeneca is developing a vaccine to combat COVID19. It expects the first cash inflow from this project to be $525,000 in 6 years’ time and then an inflow will occur every half a year for the next five years. The success of this project results in an expectation of the cash inflows growing at a rate of 11.32% p.a. compounded annually. After the patent on this vaccination expires, the long-term growth rate will drop to zero and the cash inflows will cease. If AstraZeneca requires a return of 16.48% p.a. compounded annually, what is the maximum amount of money they could put into developing this vaccine for it to be worthwhile?
Expert Solution
Semi annual rate equivalent to growth rate of 13.42% compounded annually =
(1+13.42%)^(1/2)-1= 6.498826%
Semi annual rate equivalent to rate of return of 16.48% compounded annually =
(1+16.48%)^(1/2)-1= 7.925901%
Cash inflows as stated constitute a growing annuity due of $525,000, semi annual, for 5 years, starting 6 years from now.
Maximum amount that can be invested now is the PV of this annuity, further discounted for 6 years = $ 1,981,320.03
Calculation as follows:
PLEASE SEE THE ATTACHED FILE.
Archived Solution
Unlocked Solution
You have full access to this solution. To save a copy with all formatting and attachments, use the button below.
Already a member? Sign In
Important Note:
This solution is from our archive and has been purchased by others. Submitting it as-is may trigger plagiarism detection. Use it for reference only.
For ready-to-submit work, please order a fresh solution below.
For ready-to-submit work, please order a fresh solution below.
Or get 100% fresh solution
Get Custom Quote
